The global demand for Thermal Ablation Devices Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Thermal Ablation Devices are devices that use heat to remove tissue or a part of the body, or destroy its function. Thermal ablation is a minimally invasive treatment option for various types of cancer. These devices are used in surgical procedures using an open, laparoscopic, or endoscopic approach to remove the tumour. The most common anatomic site for thermal ablation is the liver. RF electrical current, microwave radiation, laser light, and ultrasound acoustic waves are the most common sources of clinical tumour ablation. The temperature and the thermal dose required can be measure using MRI. For efficient use of these devices a thorough understanding knowledge of these devices and the technology used is important for interventional radiologists. Advanced tumour ablation procedures can be carried out on an outpatient basis and can lead to reduction in hospital costs.
The rising occurrences of chronic diseases is boosting the adoption of thermal ablation devices which is likely to fuel growth in its market. Adoption of minimally invasive operations due to their ease and less damage to the body will propel the market. Favourable reimbursement scenario, and improving economic condition will drive the thermal ablation devices market. In the current scenario where COVID-19 cases are on the rise, there is very little effect on the growing market trend since these devices are more specific to cancer treatment. The factors such as high costs of the devices, less availability of pain management therapeutics, and the development of advanced alternative therapeutics are creating hindrances to the growth of the global thermal ablation devices market.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of thermal ablation devices.
The entire thermal ablation devices market has been sub-categorized into components and end user. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By End User
- Interstitial Probes
- Grounded Probes
- Needle Applications
- Radiofrequency Ablation
- Hydrothermal Ablation
- Microwave Ablation
- Laser Ablation
- Ultrasound Ablation
- Ambulatory Surgical Centers (ASCs)
This section covers regional segmentation which accentuates on current and future demand for thermal ablation devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Thermal Ablation Devices Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the thermal ablation devices market include Medtronic Plc., Boston Scientific Corp., Smith & Nephew Plc., AngioDynamics, Inc., Abbott Laboratories, Stryker Corporation, Atricure, Inc., Halyard Health, Inc., Hologic, Inc., Johnson & Johnson, Olympus Corporation, Others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.